Our highly developed center for surgery of internal organs specializes in the surgical treatment of the following diseases:
- Malignant tumors of the esophagus
- Malignant tumors of the stomach
- Gastrointestinal tumor
- Neuroendocrine tumors
- Benign tumors of the esophagus and stomach
- Gastric and duodenal ulcer
Esophageal malignant tumors and their treatment are a specialty of our clinic. In the esophagus and when moving from the esophagus to the stomach (cardia), 4-7 out of every 100,000 people develop a malignant tumor every year. Depending on the type of tumor (adenocarcinoma or squamous cell carcinoma), localization in the esophagus and the degree of the tumor, these tumors are operated directly or pretreated with chemotherapy or chemoradiotherapy. This pre-treatment can reduce large tumors and significantly increase the likelihood of prolonged healing after surgery. In recent years, together with our colleagues in oncology and radiation therapy, we have successfully treated many patients with this combined therapy protocol. For a good treatment result, it is important, above all, close cooperation between different disciplines.
If the esophagus needs to be removed surgically due to a tumor, the stomach usually moves to the chest as a replacement, which allows the patient to swallow and eat almost normally after surgery. Such an operation is the main intervention, for which, in addition to specially trained surgeons, other specially trained doctors should be available, for example, anesthetists, intensive care doctors, endoscopists, radiologists and antenatal care doctors. In our hospital, all these specialists are ready to optimally care for patients with esophageal cancer. Benign tumors or protrusion of the esophagus (diverticula) are rare, but can cause dysphagia or other functional symptoms. In many cases, surgery can eliminate these symptoms.
Malignant tumors of the stomach (stomach cancer) occur in 20 out of every 100,000 people per year. Smaller gastric carcinomas are mainly operated on or, in exceptional cases, also removed as part of the gastroscopy. Advanced tumors today undergo chemotherapy before surgery. Pre-treatment reduces the size of large tumors and increases the likelihood of prolonged healing after surgery. In our center, most patients undergo preliminary treatment in close collaboration with specially designated oncologists and gastroenterologists. This ensures that our patients are always pre-treated with the best-acting drug.
After this pre-treatment, surgical removal of the tumor stomach is usually performed. The passage of the digestive tract is provided by the inserted part of the intestine. Patients can usually eat only in small portions after this operation. However, more frequent meals can provide adequate nutrition. Currently, specialized nutritionists help our patients.
Gastrointestinal stromal tumors (GIST) are rare tumors of the connective tissue of the digestive tract and are most commonly found in the stomach. GIST of the stomach in our clinic - depending on its volume and location - is usually minimally invasive, but in the case of large tumors, conventional surgery is also used. In addition, chemotherapy treatment is often performed after surgery, in some cases even before surgery.
Neuroendocrine tumors (NET) are very rare tumors (about 1 - 2 per 100,000 inhabitants / year) and are found mainly in the gastrointestinal tract and pancreas. Treatment today consists of surgery (gastrectomy / resection of the stomach). In special cases of NET on the stomach, there is the possibility of endoscopic or drug therapy. Pancreatic NET is treated in our clinic as part of the pancreatic cancer treatment center.
Benign tumors of the stomach are rare, but can be the cause of surgery if they have functional discomfort or are not protected from malignant tumors.